You are here

Clinical Trials: Cardiovascular Diseases

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, October 3, 2016 - 12:00
Condition:   Heart Failure With Normal Ejection Fraction
Interventions:   Biological: Cell Therapy;   Biological: Control Procedure
Sponsor:   University Medical Centre Ljubljana
Recruiting - verified October 2016
Posted: Tuesday, September 27, 2016 - 12:00
Condition:   Thoracic or Abdominal Aortic Aneurysm With no Indication for Surgical Treatment
Intervention:   Biological: blood taking
Sponsor:   Centre Hospitalier Universitaire de Besancon
Recruiting - verified September 2016
Posted: Thursday, September 22, 2016 - 12:00
Condition:   Peripheral Arterial Disease
Interventions:   Biological: G-CSF + CD133(+) cells;   Biological: G-CSF;   Procedure: percutaneous transluminal angioplasty (PTA);   Biological: Placebo infusion
Sponsor:   Shanghai 10th People's Hospital
Recruiting - verified September 2016
Posted: Monday, September 19, 2016 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: Fulvestrant
Sponsor:   University of Pennsylvania
Not yet recruiting - verified September 2016
Posted: Wednesday, August 31, 2016 - 12:00
Condition:   Coronary Artery Disease
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   First Affiliated Hospital of Harbin Medical University
Recruiting - verified August 2016
Posted: Wednesday, August 24, 2016 - 12:00
Condition:   Neonatal Hypoxic-ischaemic Encephalopathy
Intervention:   Drug: autologous cord blood stem cell
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Wednesday, August 10, 2016 - 12:00
Conditions:   Congestive Heart Failure;   Heart Failure, Diastolic
Interventions:   Biological: Allogenic Derived Cells;   Biological: Placebo/Control Arm
Sponsor:   Medical University of South Carolina
Recruiting - verified August 2016
Posted: Sunday, August 7, 2016 - 12:00
Condition:   Coronary Artery Disease
Intervention:   Biological: Transepicardial with Transseptal CD 133+ Implantation
Sponsor:   National Cardiovascular Center Harapan Kita Hospital Indonesia
Recruiting - verified August 2016
Posted: Friday, August 5, 2016 - 12:00
Condition:   Diabetic Foot Ulcer
Intervention:   Drug: adipose-derived regenerative cells (ADRCs)
Sponsor:   Assistance Publique Hopitaux De Marseille
Not yet recruiting - verified August 2016
Posted: Tuesday, August 2, 2016 - 12:00
Condition:   Pulmonary Arterial Hypertension
Intervention:   Drug: [18F] FES
Sponsor:   University of Pennsylvania
Recruiting - verified September 2016

Pages